ConductScience.org, home

Comparison · NCT00290290-sae

Povidone-Iodine vs Chlorhexidine-Alcohol: serious adverse events

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Povidone-Iodine vs Chlorhexidine-Alcohol: serious adverse events. Trial comparisons, record NCT00290290-sae. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT00290290-sae

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.006820.002320.0199wilson
Risk in group 20.009780.003810.0249wilson
Risk difference, group 1 minus group 2-0.00296-0.01870.0114newcombe hybrid score
Risk ratio, group 1 over group 20.6970.1573.1log
Odds ratio, group 1 over group 20.6950.1553.12log
Number needed to treat, for one fewer participant with a serious adverse event on Povidone-Iodine than on Chlorhexidine-Alcohol338from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Povidone-IodineSkin at surgical site preoperatively scrubbed then painted with an aqueous solution of 10% povidone-iodine3440EG000
Group 2Chlorhexidine-AlcoholSkin at surgical site preoperatively scrubbed with an applicator that contained 2% chlorhexidine gluconate and 70% alcohol4409EG001

Harm

What it counts
Total, serious adverse events
Time frame

Source ClinicalTrials.gov

Trial

Title
Efficacy Study of Antiseptic Preoperative Scrubs in Prevention of Postoperative Infections
NCT number
NCT00290290
Phases
PHASE3
Conditions
Postoperative Wound Infection
Interventions
chlorhexidine-alcohol, Povidone-Iodine
Lead sponsor
Baylor College of Medicine
Results first posted
2014-08-11

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT00290290-sae